Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8

Abstract

Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals.